Pipeline
PipelineR&D schedule
Exosome-based therapeutics
Development of Exosome-based therapeutics
- Producing artificial exosome-based therapeutics tailored for specific diseases.
- Developing pipelines for cancer, inflammation, ulcer and alopecia.
- The DABOM Inc.
- Reg No. 205-81-43826
- CEO. Hyo-Il Jung
- Tel. +82-2-2123-7767
- E-mail. contact@thedabom.com
- Address. (03722) 249, Engineering Research Park, 50,
Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea
© The DABOM Inc. ALL RIGHTS RESERVED. Design by Threeway
- Pipeline
- R&D schedule
